Package 66267-212-30

{"route": ["ORAL"], "spl_id": "1fa6a784-9fb3-c3fa-e063-6394a90add4c", "openfda": {"upc": ["0366267212908"], "unii": ["V3888OEY5R"], "rxcui": ["897649"], "spl_set_id": ["3f14442c-8178-0bad-e054-00144ff8d46c"], "manufacturer_name": ["NuCare Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (66267-212-30)", "package_ndc": "66267-212-30", "marketing_start_date": "20161017"}, {"sample": false, "description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (66267-212-90)", "package_ndc": "66267-212-90", "marketing_start_date": "20161017"}], "brand_name": "verapamil hydrochloride", "product_id": "66267-212_1fa6a784-9fb3-c3fa-e063-6394a90add4c", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "66267-212", "generic_name": "verapamil hydrochloride", "labeler_name": "NuCare Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "verapamil hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "240 mg/1"}], "application_number": "ANDA078906", "marketing_category": "ANDA", "marketing_start_date": "20090917", "listing_expiration_date": "20261231"}